APA (7th ed.) Citation

Wislez, M., Blons, H., Domblides, C., Barlesi, F., Mazieres, J., Monnet, I., . . . Lavolé, A. (2018). Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA). Annals of oncology, 29, viii507. https://doi.org/10.1093/annonc/mdy292.027

Chicago Style (17th ed.) Citation

Wislez, M., et al. "Circulating Tumor DNA (ctDNA) in Advanced Non-small Cell Lung Cancer (NSCLC) from HIV-infected Patients Is Associated to Shorter Overall Survival (OS): Results from Phase II Trial (IFCT-1001 CHIVA)." Annals of Oncology 29 (2018): viii507. https://doi.org/10.1093/annonc/mdy292.027.

MLA (9th ed.) Citation

Wislez, M., et al. "Circulating Tumor DNA (ctDNA) in Advanced Non-small Cell Lung Cancer (NSCLC) from HIV-infected Patients Is Associated to Shorter Overall Survival (OS): Results from Phase II Trial (IFCT-1001 CHIVA)." Annals of Oncology, vol. 29, 2018, p. viii507, https://doi.org/10.1093/annonc/mdy292.027.